big mover upUMACmassive
Unusual Machines, Inc. (UMAC) Surges 5.0% on Heavy Volume
Unusual Machines, Inc. (AMEX:UMAC) surged 5.0% in today's trading, closing at $27.27.
Read moreFeatured By
Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Unusual Machines, Inc. (AMEX:UMAC) surged 5.0% in today's trading, closing at $27.27.
Read moreNORGES BANK, a registered investment adviser, initiated a new position in Alphabet Inc. (NASDAQ:GOOG) during Q2 2026, according to its most recent 13F filing with the Securities…
Read moreNano One Materials (NASDAQ:NANO) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreNORGES BANK, a registered investment adviser, initiated a new position in Alphabet Inc. (NASDAQ:GOOGL) during Q2 2026, according to its most recent 13F filing with the Securities…
Read moreSCHMID Group N.V. Class A Ordinary Shares (NASDAQ:SHMD) surged 5.0% in today's trading, closing at $5.25.
Read moreAnnexon (NASDAQ:ANNX) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreNORGES BANK, a registered investment adviser, initiated a new position in Amazon.com, Inc. (NASDAQ:AMZN) during Q2 2026, according to its most recent 13F filing with the…
Read moreAvalyn Pharma (NASDAQ:AVLN) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreNORGES BANK, a registered investment adviser, initiated a new position in Microsoft Corporation (NASDAQ:MSFT) during Q2 2026, according to its most recent 13F filing with the…
Read moreUnicycive Therapeutics (NASDAQ:UNCY) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreNORGES BANK, a registered investment adviser, initiated a new position in Apple Inc. (NASDAQ:AAPL) during Q2 2026, according to its most recent 13F filing with the Securities and…
Read moreCNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreNORGES BANK, a registered investment adviser, initiated a new position in NVIDIA Corporation (NASDAQ:NVDA) during Q2 2026, according to its most recent 13F filing with the…
Read moreXilio Therapeutics (NASDAQ:XLO) reported quarterly earnings results on August 12, 2026 that exceeded analyst expectations.
Read moreLexeo Therapeutics (NASDAQ:LXEO) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreCentury Therapeutics (NASDAQ:IPSC) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreTScan Therapeutics (NASDAQ:TCRX) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read morePharvaris (NASDAQ:PHVS) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreAdagene (NASDAQ:ADAG) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read moreSutro Biopharma (NASDAQ:STRO) reported quarterly earnings results on August 12, 2026 that fell short of analyst expectations.
Read more